Skip to main content

An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model.

Author
Abstract
:

Early detection of Alzheimer's disease (AD) pathology is a serious challenge for both diagnosis and clinical trials. The aspartyl protease, Cathepsin D (CatD), is overexpressed in AD and could be a biomarker of disease. We have previously designed a unique contrast agent (CA) for dual-optical and magnetic resonance imaging of the activity of the CatD class of enzymes.

Year of Publication
:
0
Journal
:
Journal of Alzheimer's disease : JAD
Volume
:
61
Issue
:
3
Number of Pages
:
1241-1252
Date Published
:
2018
ISSN Number
:
1387-2877
URL
:
https://content.iospress.com/openurl?genre=article&id=doi:10.3233/JAD-170115
DOI
:
10.3233/JAD-170115
Short Title
:
J Alzheimers Dis
Download citation